盟科药业：股东Best Idea、JSR及GP TMT计划减持公司股份合计不超过约3934万股

Group 1 - The core point of the news is that Shanghai Mengke Pharmaceutical Co., Ltd. announced a share reduction plan by its major shareholders, which may impact the stock price and investor sentiment [1] - Best Idea International Limited holds approximately 58.44 million shares, accounting for 8.91% of the total shares of the company [1] - JSR Limited and GP TMT Holdings Limited hold approximately 30.84 million shares (4.7%) and 18.37 million shares (2.8%) respectively, with JSR and GP TMT being acting in concert, collectively holding about 49.22 million shares (7.51%) [1] Group 2 - The shareholders plan to reduce their holdings by up to approximately 39.34 million shares, which is not more than 6% of the total share capital of the company [1] - As of the announcement, the market capitalization of Mengke Pharmaceutical is 5.1 billion yuan [2]